News

AstraZeneca announces results from Phase III SOLO-2 trial designed to determine the efficacy of Lynparza as a monotherapy for ovarian cancer.

Users of Autoscribe Informatics’ Matrix LIMS (Laboratory Information Management Systems) recently attended a busy User Group Meeting at the Williams F1 Centre in Oxfordshire, UK.

Scientists discover bacteria found in marine animals can fix nitrogen as well as carbon.

For patients with severe, chronic back and leg pain, a new high-frequency spinal cord stimulation (SCS) technique provides superior clinical outcomes, compared to conventional low-frequency SCS, reports a clinical trial in Neurosurgery.

Autism and ADHD experts say current measuring tools for ADHD may not work for children with autism spectrum disorders.

The distinct structures of toxic protein aggregates that form in degenerating brains determine which type of dementia will occur, which regions of brain will be affected, and how quickly the disease will spread, according to a study from the Peter O'Donnell Jr.

In a remarkable "two for one" discovery, scientists from the Florida campus of The Scripps Research Institute (TSRI) have illuminated a key molecular player in the addictive effects of morphine in animal models.

Penn Medicine research challenges previous findings on utility of neutrophil-to-lymphocyte ratio as a biomarker.

Researchers have developed a non-toxic strain of Salmonella to penetrate and target cancer cells.

The study found that topical treatment of an Hsp60-containing gel dramatically accelerates wound closure in a diabetic mouse model.